NCT02322619View on ClinicalTrials.gov

Bio-equivalency Study of Moxifloxacin Tablets, 400 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

Moxifloxacin Tablets 400 mg

Moxifloxacin Tablets 400 mg of Dr. Reddy's Laboratories Limited

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY